Search Results - "Gitau, Mark M."
-
1
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program
Published in Surgery open science (01-10-2020)“…Treatment paradigms for borderline resectable pancreatic cancer are evolving with increasing use of neoadjuvant chemotherapy and neoadjuvant chemoradiation…”
Get full text
Journal Article -
2
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study
Published in Journal of clinical oncology (20-07-2020)“…Pembrolizumab is a humanized monoclonal antibody that blocks interaction between programmed death receptor-1 (PD-1) and its ligands (PD-L1, PD-L2). Although…”
Get full text
Journal Article -
3
Heparin-induced thrombocytopenia
Published in Missouri medicine (01-01-2009)“…Heparin-Induced Thrombocytopenia (HIT) is a well recognized, potentially life-threatening, complication of heparin therapy. It is associated with an increased…”
Get more information
Journal Article -
4
Phase II study of dichloroacetate (DCA) in combination with chemoradiation (CRT) for unresected, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN)
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
5
KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article